134 related articles for article (PubMed ID: 19667148)
1. Regulation of steroid receptor expression by 1alpha-hydroxyvitamin D5 in hormone-responsive breast cancer cells.
Hussain-Hakimjee EA; Mehta RG
Anticancer Res; 2009 Sep; 29(9):3555-61. PubMed ID: 19667148
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5.
Peng X; Jhaveri P; Hussain-Hakimjee EA; Mehta RG
Carcinogenesis; 2007 May; 28(5):1000-7. PubMed ID: 17130524
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition of carcinogen-transformed MCF-12F breast epithelial cells and hormone-sensitive BT-474 breast cancer cells by 1alpha-hydroxyvitamin D5.
Hussain-Hakimjee EA; Peng X; Mehta RR; Mehta RG
Carcinogenesis; 2006 Mar; 27(3):551-9. PubMed ID: 16195238
[TBL] [Abstract][Full Text] [Related]
4. Identification of VDR-responsive gene signatures in breast cancer cells.
Towsend K; Trevino V; Falciani F; Stewart PM; Hewison M; Campbell MJ
Oncology; 2006; 71(1-2):111-23. PubMed ID: 17377416
[TBL] [Abstract][Full Text] [Related]
5. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin metabolizing enzymes in correlation with vitamin D receptor in benign and malignant breast cell lines.
Thill M; Fischer D; Becker S; Cordes T; Dittmer C; Diedrich K; Salehin D; Friedrich M
Anticancer Res; 2009 Sep; 29(9):3619-25. PubMed ID: 19667157
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D3 up-regulates the renal vitamin D receptor through indirect gene activation and receptor stabilization.
Healy KD; Frahm MA; DeLuca HF
Arch Biochem Biophys; 2005 Jan; 433(2):466-73. PubMed ID: 15581603
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and mechanism of action of 1alpha-hydroxy-24-ethyl-cholecalciferol (1alpha[OH]D5) in breast cancer prevention and therapy.
Hussain EA; Mehta RR; Ray R; Das Gupta TK; Mehta RG
Recent Results Cancer Res; 2003; 164():393-411. PubMed ID: 12899538
[TBL] [Abstract][Full Text] [Related]
11. 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer.
Nakagawa K; Kawaura A; Kato S; Takeda E; Okano T
Carcinogenesis; 2005 Feb; 26(2):429-40. PubMed ID: 15539405
[TBL] [Abstract][Full Text] [Related]
12. Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells.
Banwell CM; MacCartney DP; Guy M; Miles AE; Uskokovic MR; Mansi J; Stewart PM; O'Neill LP; Turner BM; Colston KW; Campbell MJ
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2004-13. PubMed ID: 16609009
[TBL] [Abstract][Full Text] [Related]
13. MAPK inhibition by 1alpha,25(OH)2-Vitamin D3 in breast cancer cells. Evidence on the participation of the VDR and Src.
Rossi AM; Capiati DA; Picotto G; Benassati S; Boland RL
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):287-90. PubMed ID: 15225787
[TBL] [Abstract][Full Text] [Related]
14. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.
Essa S; Reichrath S; Mahlknecht U; Montenarh M; Vogt T; Reichrath J
Anticancer Res; 2012 Jan; 32(1):383-9. PubMed ID: 22213330
[TBL] [Abstract][Full Text] [Related]
15. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.
Seifert M; Rech M; Meineke V; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):375-9. PubMed ID: 15225804
[TBL] [Abstract][Full Text] [Related]
16. 1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1-promoter demethylation.
Lopes N; Carvalho J; Durães C; Sousa B; Gomes M; Costa JL; Oliveira C; Paredes J; Schmitt F
Anticancer Res; 2012 Jan; 32(1):249-57. PubMed ID: 22213313
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics.
Seubwai W; Wongkham C; Puapairoj A; Khuntikeo N; Wongkham S
Cancer; 2007 Jun; 109(12):2497-505. PubMed ID: 17487855
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin metabolising enzymes and PGE2 are inversely correlated with vitamin D receptor and 25(OH)2D3 in breast cancer.
Thill M; Fischer D; Hoellen F; Kelling K; Dittmer C; Landt S; Salehin D; Diedrich K; Friedrich M; Becker S
Anticancer Res; 2010 May; 30(5):1673-9. PubMed ID: 20592360
[TBL] [Abstract][Full Text] [Related]
19. Regulation of gene expression of epithelial calcium channels in intestine and kidney of mice by 1alpha,25-dihydroxyvitamin D3.
Okano T; Tsugawa N; Morishita A; Kato S
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):335-8. PubMed ID: 15225796
[TBL] [Abstract][Full Text] [Related]
20. TRPC3-like protein and vitamin D receptor mediate 1alpha,25(OH)2D3-induced SOC influx in muscle cells.
Santillán G; Katz S; Vazquez G; Boland RL
Int J Biochem Cell Biol; 2004 Oct; 36(10):1910-8. PubMed ID: 15203106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
